Coeptis Therapeutics received a notice from Nasdaq stating that it is not currently in compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market.
AI Assistant
COEPTIS THERAPEUTICS HOLDINGS INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.